Li Xueyan, Yang Zhaoyi, Yu Denghui, Zhang Yiwen, Shen Zhixin, Meng Yansong, Ding Yuling, Li Yong
School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun, Jilin, 130117, China.
School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun, Jilin, 130117, China.
J Ethnopharmacol. 2025 Aug 29;352:120171. doi: 10.1016/j.jep.2025.120171. Epub 2025 Jun 21.
Inflammation is an important physiological process that serves as the host's defense mechanism against tissue damage, stress, or oxidative stress. As a traditional medicinal and edible plant, Ecklonia kurome (EK) is used to treat galls and scrofula, which is now known as lymphatic tuberculosis and lymphadenitis, but the specific effective medicinal ingredients of EK are not clear, and further exploration is needed for its anti-inflammatory activity.
This study aims to extract, isolate and purify EK, and investigate its pharmacological effects, in order to explore the chemical composition, toxicity and anti-inflammatory activity of EK.
Silica gel, Sephadex gel (LH-20) and other column chromatography methods were used to separate and purify the ethanol extract of EK, and the zebrafish embryo model was used to conduct toxicity evaluation research. The anti-inflammatory activity of monomer compounds was predicted and verified based on molecular docking technology. The lipopolysaccharide induced cell inflammation model was tested to detect NO, reactive oxygen species (ROS), interleukin-6 (IL-6), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and prostaglandin E2 (PGE2) Study the expression level of indicators and investigate the therapeutic effect of EK on inflammatory cells.
Eight compounds were isolated from EK, namely Ishigoside (1), Squalene (2), δ-tocopherol (3), Phytol (4), Di - (2-ethylhexyl) phthalate (5), 1,3-dilinoloylglycerol (6), Fuchosterol (7), and Mannitol (8). Compound 1 was isolated from EK for the first time, while compounds 2-6 were reported for the first time.; The toxicity test results showed that compounds 1-8 did not produce zebrafish embryonic developmental toxicity at 12.5, 25, 50, and 100 μ M; The molecular docking results showed that the new compound had a good binding effect with inflammatory factors; The anti-inflammatory experiment results of RAW264.7 cells showed that compounds 1-8 did not produce cytotoxicity at 3, 10, 30, and 100 nM, but significantly increased cell viability and inhibited NO in cells, The levels of ROS, IL-6, IL-1β, TNF-α, and PGE2.
The research results indicate that compounds derived from EK can significantly reduce the expression levels of inflammatory cytokines and are safe, suggesting that EK has certain application prospects and can be further developed and utilized.
炎症是一种重要的生理过程,是机体抵御组织损伤、应激或氧化应激的防御机制。作为一种传统的药食两用植物,昆布用于治疗瘰疬,即现在所知的淋巴结核和淋巴结炎,但其具体有效的药用成分尚不清楚,其抗炎活性有待进一步探索。
本研究旨在对昆布进行提取、分离和纯化,并研究其药理作用,以探索昆布的化学成分、毒性和抗炎活性。
采用硅胶、葡聚糖凝胶(LH-20)等柱色谱方法对昆布乙醇提取物进行分离纯化,采用斑马鱼胚胎模型进行毒性评价研究。基于分子对接技术预测并验证单体化合物的抗炎活性。通过脂多糖诱导细胞炎症模型检测一氧化氮(NO)、活性氧(ROS)、白细胞介素-6(IL-6)、白细胞介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)和前列腺素E2(PGE2)等指标的表达水平,研究昆布对炎症细胞的治疗作用。
从昆布中分离得到8种化合物,分别为石花菜苷(1)、角鲨烯(2)、δ-生育酚(3)、叶绿醇(4)、邻苯二甲酸二(2-乙基己基)酯(5)、1,3-二亚麻酰甘油(6)、岩藻甾醇(7)和甘露醇(8)。化合物1首次从昆布中分离得到,化合物2-6为首次报道;毒性试验结果表明,化合物1-8在12.5、25、50和100μM浓度下均未产生斑马鱼胚胎发育毒性;分子对接结果表明,新化合物与炎症因子具有良好的结合效果;RAW264.7细胞抗炎实验结果表明,化合物1-8在3、10、30和100 nM浓度下均未产生细胞毒性,但显著提高细胞活力并抑制细胞内NO、ROS、IL-6、IL-1β、TNF-α和PGE2的水平。
研究结果表明,昆布来源的化合物可显著降低炎症细胞因子的表达水平且安全性良好,提示昆布具有一定的应用前景,可进一步开发利用。